Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 1;53(3):110-124.
doi: 10.1249/JES.0000000000000360. Epub 2025 Feb 18.

Exercise May Improve Completion of Standard and Emerging Cancer Treatments

Ignacio Catalá-Vilaplana, Sabrina E Cao, Kendra Zadravec, Nathalie LeVasseur, Randall J Kimple, Amy J Lim  1 , Kerry S Courneya  2 , Kristin L Campbell
Affiliations
Review

Exercise May Improve Completion of Standard and Emerging Cancer Treatments

Ignacio Catalá-Vilaplana et al. Exerc Sport Sci Rev. .

Abstract

Receipt of the entire course of intended anticancer treatment is critical to maximize treatment efficacy, reduce risk of disease recurrence, and improve survival. Engaging in an exercise program during cancer treatment has the potential to improve treatment completion, but standardization in terminology for reporting on cancer treatment completion is needed, especially as types of cancer treatments continue to evolve.

Keywords: aerobic training; cancer treatment completion; exercise oncology; medication adherence; relative dose intensity; resistance training.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: NL reports receiving advisory role fees from Astra Zeneca, Eli Lilly, Gilead, Merck, Knight Therapeutics, Merck, Novartis, Pfizer, Roche, Seagen, TerSera; speaker’s honoraria from Astra Zeneca, Eli Lilly, Gilead, Merck, Knight Therapeutics, Merck, Novartis, Pfizer, Roche, Seagen, TerSera; and research funds to institution from Abbvie, Astra Zeneca, Eli Lilly, Exact Sciences, Gilead, Pfizer, Roche. RJK acknowledges the following conflicts of interest: Advisory board: Guidepoint Global; consultant: HunaTek Inc.

References

    1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3):229–63. - PubMed
    1. Tonorezos E, Devasia T, Mariotto AB, Mollica MA, Gallicchio L, Green P, et al. Prevalence of cancer survivors in the United States. JNCI: Journal of the National Cancer Institute. 2024. Jul 13;djae135. - PMC - PubMed
    1. Smyth MJ. Multiple approaches to immunotherapy - the new pillar of cancer treatment. Immunol Cell Biol. 2017. Apr;95(4):323–4. - PubMed
    1. Zhou Z, Li M. Targeted therapies for cancer. BMC Med. 2022. Mar 11;20(1):90. - PMC - PubMed
    1. Trommer M, Marnitz S, Skoetz N, Rupp R, Niels T, Morgenthaler J, et al. Exercise interventions for adults with cancer receiving radiation therapy alone. Cochrane Database of Systematic Reviews [Internet] 2023. [cited 2024 Jul 11];(3). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013448.pub2/... - DOI - PMC - PubMed